Overview
Mara Hofstetter practices practicing medicine in Zurich, Switzerland.
Her clinical expertise encompasses Adult T-Cell Leukemia, Acute Myeloid Leukemia (AML), and Leukemia.
She is actively involved in clinical research, co-authoring 10 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Mara C. Hofstetter
Is Mara C. Hofstetter a top-rated expert for Adult T-Cell Leukemia?
MediFind is an objective health platform that identifies experts based on real-world data. Mara C. Hofstetter is classified as an Experienced expert for Adult T-Cell Leukemia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Mara C. Hofstetter participate in research or clinical trials?
Yes. Mara C. Hofstetter has published 10 articles and abstracts on conditions like Adult T-Cell Leukemia. You can view a list of Mara C. Hofstetter's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acute Myeloid Leukemia (AML)Ms. Hofstetter isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Adult T-Cell LeukemiaMs. Hofstetter isExperienced. Learn about Adult T-Cell Leukemia.
- LeukemiaMs. Hofstetter isExperienced. Learn about Leukemia.